Healthcare / Health Information ServicesHKSE
$1.01
+0.02 (+2.02%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $8.1M · quality 27.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
33/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$850M
P/E
N/A
•EV/EBITDA
39.2x
↑ROE
-12.4%
↓Gross Margin
27.3%
↓Debt/Equity
1.66
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-12.3%
FCF CAGR
—
FCF margin
7.6%
FCF / Net income
-0.90x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $464.1M · net income $-38.9M · FCF $35.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $464.1M | $464.1M | $501.5M | $537.7M | $687.4M |
| Net Income | $-38.9M | $-38.9M | $-83.1M | $-154.7M | $-242.0M |
| EBITDA | $21.0M | $21.0M | $-28.5M | $-75.7M | $-161.4M |
| EPS | — | — | -0.10 | -0.23 | -0.29 |
| Gross Margin | 27.3% | 27.3% | 29.4% | 30.6% | 24.5% |
| Operating Margin | -11.8% | -11.8% | -7.0% | -18.9% | -22.8% |
| Net Margin | -8.4% | -8.4% | -16.6% | -28.8% | -35.2% |
| Balance Sheet | |||||
| Debt/Equity | 1.66 | 1.66 | 1.58 | 1.41 | -1.27 |
| Current Ratio | 1.18 | 1.18 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $35.1M | $35.1M | $8.1M | $-24.4M | $-81.2M |
| Returns | |||||
| ROE | -12.4% | -12.4% | -22.9% | -36.1% | 53.5% |
| Valuation | |||||
| EV/EBITDA | 39.22 | 39.22 | — | — | — |
| P/B | 2.71 | 2.71 | 1.92 | 2.12 | — |
| Growth & Yield | |||||
| Revenue Growth | -7.4% | -7.4% | -6.7% | -21.8% | — |
| EPS Growth | — | — | 56.5% | 20.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+11.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.10 → n/d
Residual
+11.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.